Matrix-bound nanovesicles as epigenetic modulators of myeloid cells

Area of Science:

• Cell Biology
• Immunology
• Epigenetics

Background:

• Extracellular vesicles (EV) mediate cell-to-cell communication.
• Matrix-bound nanovesicles (MBV), a type of EV, exhibit durable immunomodulatory effects on myeloid cells.
• The mechanism behind MBV's prolonged effects, even beyond myeloid cell lifespan, remains unclear.

Purpose of the Study:

• To investigate MBV-directed epigenetic modification in myeloid precursors.
• To explore the role of epigenetics in the sustained immunomodulatory effects of MBV.
• To understand how MBV influence myeloid cell differentiation and response.

Main Methods:

• Flow cytometry to analyze cell populations.
• ATAC sequencing to assess chromatin accessibility.
• Treatment of myeloid progenitors and differentiated macrophages with MBV.

Main Results:

• MBV are internalized by both myeloid progenitors and differentiated macrophages.
• MBV internalization induces epigenetic changes, modulating macrophage inflammatory responses.
• MBV treatment alters chromatin accessibility differently in progenitors versus macrophages.

Conclusions:

• MBV induce epigenetic modifications in myeloid cells, potentially explaining their prolonged immunomodulatory effects.
• Epigenetic reprogramming by MBV offers a mechanism for sustained immune modulation.
• MBV represent a potential therapeutic strategy leveraging biologic scaffold materials for immune system manipulation.